Prevalence of Associated Endocrine Diseases in Patients with Neurofibromatosis Type 1

Author:

Alshahrani Aysha1,Abuoliat Zainah2,Alshahrani Awad Saad34,Al Balwi Mohammed Ali45ORCID

Affiliation:

1. Family Medicine Department, King Fahad Medical City, Riyadh, Saudi Arabia

2. Dermatology Department, King Salman bin AbdulAziz Hospital, Riyadh, Saudi Arabia

3. Division of Adult Endocrinology, Department of Medicine, King Abdulaziz Medical City, Riyadh, Saudi Arabia

4. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia

5. Division of Molecular pathology section, Department of Pathology, King Abdulaziz Medical City, Riyadh, Saudi Arabia

Abstract

Abstract Background Neurofibromatosis type 1 (NF-1) is an autosomal dominant neurocutaneous disorder that increases the risk of developing benign and malignant tumors. Several associated endocrine diseases in NF-1 patients have been explained in the literature. Thus, this study aims to assess the endocrine manifestations as there no previous local data have discussed this association. Methods A retrospective cross-sectional study was conducted at KAMC and KASCH, Riyadh, Saudi Arabia by including all patients genetically confirmed with NF1 from 2004 until 2019 using a consecutive non-probability sampling technique. The included data were demographics, consanguinity, genetic variant mutations as well as associated endocrine diseases. Results The prevalence of patients with associated endocrine diseases was estimated to be 19.4%. Short stature showed the highest frequency of associated endocrine diseases followed by subclinical hypothyroidism. Positive consanguinity, sporadic mutation, and pathogenic variant showed high frequencies. Conclusion The coexistence of endocrine diseases was found in NF-1 patients. Therefore, screening for endocrine abnormality in patients with NF-1 by comprehensive history and physical exam as well as investigations to minimize complications and the late presentation should be considered; however, further studies are necessary to address the need.

Publisher

Georg Thieme Verlag KG

Reference25 articles.

1. Thyroid Gland 18F-FDG Uptake in Neurofibromatosis Type 1;Z YGJ van Lierop;Eur Thyroid J,2018

2. Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1;C L Wong;Endocrinol Diabetes Metab Case Rep,2018

3. Endocrine dysfunction in neurofibromatosis type 1–an update;R Pop;Acta Med Marisiensis,2016

4. Precise localization of NF1 to 17q11.2 by balanced translocation;D H Ledbetter;Am J Hum Genet,1989

5. Epidemiology of neurofibromatosis type 1 (NF1) in northern Finland;M Poyhonen;J Med Genet,2000

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3